PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 159 filers reported holding PTC THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,770,000 | -30.4% | 162,274 | -10.6% | 0.00% | -33.3% |
| Q3 2016 | $2,542,000 | +97.5% | 181,471 | -1.0% | 0.00% | +50.0% |
| Q2 2016 | $1,287,000 | +27.3% | 183,317 | +16.8% | 0.00% | +100.0% |
| Q1 2016 | $1,011,000 | -77.4% | 156,956 | +13.5% | 0.00% | -83.3% |
| Q4 2015 | $4,479,000 | +22.7% | 138,246 | +1.1% | 0.01% | +20.0% |
| Q3 2015 | $3,650,000 | -45.5% | 136,688 | -1.8% | 0.01% | -37.5% |
| Q2 2015 | $6,697,000 | +14.7% | 139,146 | +45.1% | 0.01% | 0.0% |
| Q1 2015 | $5,837,000 | +24.8% | 95,918 | +6.2% | 0.01% | +33.3% |
| Q4 2014 | $4,676,000 | +62.2% | 90,328 | +37.9% | 0.01% | +50.0% |
| Q3 2014 | $2,882,000 | +69.8% | 65,486 | +0.9% | 0.00% | +100.0% |
| Q2 2014 | $1,697,000 | +99.9% | 64,901 | +99.9% | 0.00% | +100.0% |
| Q1 2014 | $849,000 | +83.0% | 32,462 | +18.8% | 0.00% | 0.0% |
| Q4 2013 | $464,000 | -17.9% | 27,331 | +3.8% | 0.00% | 0.0% |
| Q3 2013 | $565,000 | – | 26,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |